Roivant Sciences Ltd. (ROIV) Tops Q4 EPS by 57c
Tweet
Share
E-mail
Get Alerts ROIV Hot Sheet
Join SI Premium – FREE
Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q4 EPS of $0.28, $0.57 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $2.52 million versus the consensus estimate of $3.76 million.
For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Upgrades 1&1 AG (1U1:GR) to Overweight
- Nomura/Instinet Resumes Toyota Tsusho Corp (8015:JP) at Buy
- RBC Capital Starts Enact Holdings Inc (ACT) at Sector Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
